The initiation of human pregnancy requires precisely timed development of the endometrium to receive the implanting blastocyst. The ovarian steroid hormones are essential for development and maintenance of a hospitable uterine environment. The hormonal regimes employed in assisted reproduction procedures are known to alter the abundance of specific endometrial receptors for these steroids. Since, in the presence of ligand, the progesterone receptor (PR) is known to be modified by the small intracellular protein ubiquitin, we have investigated the localization of ubiquitin and PR within the endometrial glands of 28 fertile women during a monitored menstrual cycle and also during a stimulated cycle prior to oocyte donation. We have also observed the number of gland cells undergoing cell division as demonstrated by the presence of Ki67 immunostaining. We demonstrate that the percentage of ubiquitin-positive nuclei increases from day four post-ovulation to day 10 post-ovulation in the natural cycle, but that this increase is not seen during a stimulated cycle. The presence of PR within glandular epithelium and the proliferation of gland cells were only observed during the early secretory phase and did not appear to vary significantly between the two cycles. We conclude that ubiquitin may play an important role in endometrial development and that perturbation of ubiquitin may be related to the lower implantation rate seen in the stimulated cycle.
Introduction
the endometrium in the stimulated cycle (Garcia et al., 1984; Forman et al., 1989; Navot et al., 1989; Sharma et al., 1990 ; Donated human eggs have been in clinical use for the treatment Ben-Nun et al., 1992; Seif et al., 1992; Macrow et al., 1994 ; of infertility since 1984, when Lutjen et al. reported the first Kolb and Paulson, 1997 ). It appears that shortly after ovulation successful pregnancy resulting from oocyte donation, IVF and induction the endometrial stroma is advanced in development embryo transfer (Lutjen et al., 1984) . In contrast to standard (Garcia et al., 1984; Forman et al., 1989; Kolb and Paulson, IVF procedures (where the female is stimulated by administra-1997), particularly in terms of premature spiral artery formation tion of exogenous gonadotrophins to produce a supra-physio- (Seif et al., 1992; Macrow et al., 1994) , while endometrial logical number of mature eggs at the time of treatment), oocyte glands may be retarded in comparison to those of control recipients may undergo embryo transfer during a natural or groups (Navot et al., 1989; Seif et al., 1992) . programmed menstrual cycle. In the latter instance, the amounts
The circulating ovarian hormones, oestrogen and of steroid hormones administered are still much less than the progesterone, act through specific nuclear receptors to induce concentrations observed in stimulated cycles. differentiation of the endometrium and to maintain an environThe sharing of oocytes between donors and recipients ment suitable for implantation. Progesterone receptor (PR) enables comparisons to be made whilst controlling for oocyte levels may be up-regulated by oestrogens and down-regulated quality. In one such study, where the quality of embryos by the presence of progesterone (Kreitmann et al., 1979) . transferred and age of patients were matched, the implantation Increased serum steroid hormone concentrations following rate in the donors was found to be significantly less than that ovarian stimulation may, therefore, have profound effects on in the recipients (Check et al., 1992) . This difference in endometrial steroid hormone receptor density, and indeed there implantation rate may be due to the effects of the clomiphene is evidence that ovulation induction may affect the level of citrate/human menopausal gonadotrophin (HMG)/human steroid receptors present within endometrial epithelial or chorionic gonadotrophin (HCG) regimen administered on endostromal cells (Hadi et al., 1994) . This may be a key factor metrial development. However, another explanation for this in the reduced implantation rate seen following ovulation could be that oocyte donors may have underlying endometrial induction. defects, which would be less common in oocyte recipients.
Ubiquitin is a small regulatory protein involved in the Implantation of the human embryo may only occur within covalent tagging of intracellular proteins to mark them for a tightly regulated 'window of implantation' on days 6-10 post-ovulation. A number of studies have attempted to date proteolysis (reviewed in Hershko and Ciechanover, 1998). We have previously demonstrated the presence of antifollowed by repeated rinses in TBS unless stated otherwise.
ubiquitin immunoreactivity within nuclei of human glandular
Anti-ubiquitin immunoreactivity was demonstrated by incubation epithelial cells of the late secretory phase endometrium with rabbit polyclonal antibody to ubiquitin (Dako) for 1 h, detected using biotinylated goat anti-rabbit immunoglobulin G (IgG) (Vector (Bebington et al., 1999) . The purpose of this study was to compared ubiquitin immunoreactivity with localization of the min. Bound primary antibody was detected as described for the anti-PR and to cell proliferation within these tissues.
ubiquitin antibody. The presence of PR was indicated by probing with two murine monoclonal antibodies to the human PR, recognizing either the PR-B isoform only or both PR-A and PR-B equally (Clarke et al., 1987) .
Materials and methods
Antibodies were generously donated by Dr C.Clarke, Westmead
Sample collection
Hospital, Sydney, Australia. Immunodetection followed heat-mediated Endometrial biopsies were obtained from a total of 28 previously antigen retrieval procedures performed in an autoclave at 121°C for fertile oocyte donors (age range 25-35 years) attending clinics at the 30 min in 0.01 mol/l citrate buffer, pH 6.0. Primary antibody was Nottingham University Research and Treatment Unit in Reproduction employed at room temperature overnight and was detected using (NURTURE) at the Division of Reproductive Medicine, Queen's biotinylated rabbit anti-mouse IgG (Dako) for 30 min followed Medical Centre, Nottingham, UK, and ethical approval was also by avidin-biotinylated horseradish peroxidase complex (Vector) for obtained from that institution. Informed consent was obtained from 30 min. each patient. Tissue was collected at four time-points, at days four In all immunodetection protocols, bound avidin-biotinylated and 10 post-LH-surge of a monitored menstrual cycle, and also at horseradish peroxidase was visualized using 3,3Ј diaminobenzidine days four and 10 after administration of HCG during the subsequent and H 2 O 2 (Sigma). Following antibody detection, sections were stimulated cycle. All human tissue was obtained with the approval counterstained using Harris' haematoxylin (BDH, Poole, UK) and of the Ethics Committee of NURTURE, Queen's Medical Centre, were then dehydrated and mounted in DPX (BDH). Nottingham.
Ovarian stimulation was achieved using a standard protocol com-
Statistical analysis bination of pituitary down-regulation with a gonadotrophin releasing
Immunostaining was observed using bright-field microscopy. The hormone (GnRH) agonist (buserelin: Suprefact ® , Hoechst, Hounslow, percentage of gland cell nuclei immunopositive when probed with UK; Naferelin: Synarel ® , Searle, High Wycombe, UK), and follicular each antibody was observed within 300 cells counted in three stimulation with gonadotrophins (Humegon ® : Organon, Cambridge, randomly-chosen fields of view on each section. The data were UK; Pergonal ® : Serono, Welwyn Garden City, UK) using 2-4 analysed using both the paired t-test and the Wilcoxon matched-pairs ampoules daily, followed by initiation of ovulation induction, 36 h signed-ranks test. Although both methods concurred at the 95% prior to oocyte retrieval, using 10 000 IU HCG (Profasi ® : Serono).
confidence interval, only the latter is presented due to the fact that Endometrial biopsies were obtained from the fundal region of the we could not assume a normal distribution of the data. uterus using a Pipelle (Laboratoire CCD, Paris, France). Tissues were immediately fixed in 4% (w/v) paraformaldehyde and embedded in paraffin wax, allowing the generation of 4 µm sections which were cut onto glass slides pre-treated with poly-L-lysine (Sigma, Poole, UK).
Results
A total of 62 endometrial biopsies were studied from 28 patients.
A proportion of glandular epithelial cells showed nuclear Of these, 13 were obtained at day four and 12 at day 10 post-LH staining when probed with each of the antibodies employed surge of the natural cycle (10 women were studied at both time- (Figures 1-4) . This immunoreactivity varied considerably points). During the stimulated cycle, 19 biopsies were taken four with timing of the biopsy and (in the case of anti-ubiquitin days after HCG administration and 18 at day 10 post-HCG (16 immunoreactivity) also between the natural and stimulated women were studied at both time-points). Matched biopsies from six women were obtained at each of the four stages of the study cycles. No cytoplasmic reactivity was observed when tissues were probed with the anti-PR or anti-Ki67 antibodies, but considerable cytoplasmic ubiquitin was detected using rabbit antiubiquitin (Figure 1) . Occasional stromal cells displayed immunoreactivity with all four antibodies employed. Omission of primary antibody or substitution of non-immune serum of the same species as the primary antibody eliminated staining (data not shown).
Anti-ubiquitin immunoreactivity was observed in both nuclei and cytoplasm of the glandular epithelium as well as in occasional stromal cells (e.g. Figure 1B ). In the natural menstrual cycle, an increase in the median percentage of immunopositive gland cell nuclei was seen, rising from 5% (range 0-20%) to 34% (range 1-89%) in the late secretory phase (Figure 1A and B; Figure 4A ). In the stimulated cycle, however, no increase of similar magnitude was seen. Median values in the stimulated cycle were 2% (range 0-25%) and 7% (range 0-25%) at day four and day 10 following HCG administration (Figure 1C, D; Figure 4A ). The density of ubiquitin immunopositive gland cell nuclei from day 10 following ovulation in the natural cycle was significantly higher than that of the stimulated cycle (P Ͻ 0.05).
Tissue was obtained, processed and probed with rabbit polyclonal PR abundance varied considerably within the tissues studied.
antibody to the proliferation marker, Ki67 as described in the text.
Little or no anti-PR immunoreactivity was seen in tissue from Figure 4B ) with median values of 93% (range 92-97%) and 95% (range 90-98%) in the natural and stimulated cycles respectively. Total PR immunoreactivity also appeared similar in both cycles. In the early secretory phase, immunostaining was intense while only faint reactivity was observed in the late secretory tissues.
No gland cell proliferation was seen in the late secretory (day 10 post-ovulation) tissue in either the natural or stimulated cycle ( Figure 3B ,D and Figure 4C) . A moderate number of nuclei from the early secretory phase were immunoreactive with anti-Ki67 in both cycles ( Figure 3A ,C and Figure 4C ). The early secretory phase of the natural cycle demonstrated a median score of 8% positive cells (range 5-12%) while in the stimulated cycle a median value of 9% of glandular epithelial cells contained immunopositive nuclei (range 1-12%).
Discussion
When sharing the same batch of oocytes, the implantation rate in women subjected to the hormonal stimulation necessary for ovulation induction is reduced in comparison to oocyte recipients (Check et al., 1992) . The reduced implantation rate in the stimulated cycle may be due to advanced endometrial stromal maturity accompanying retarded glandular development (Navot et al., 1989; Seif et al., 1992) or to altered abundance of endometrial steroid receptors (Hadi et al., 1994) .
Ubiquitylation and ubiquitin-mediated degradation of the PR of the chicken oviduct has recently been demonstrated (Syvälä et al., 1998) . We have previously shown the presence of ubiquitin within endometrial glandular epithelium throughout the menstrual cycle and in the nuclei of decidualized stromal cells in the first trimester of pregnancy (Bebington et al., 1999) . The presence of nuclear ubiquitin in the endometrial glands and stroma appears to be inversely correlated with that of published observations of PR levels (Wang et al., 1994 (Wang et al., , 1998 Bebington et al., 1999) . Therefore, we postulated that immunoreactivity in the stimulated cycle may indicate increased PR presence within the late secretory phase of the stimulated cycle. No such increase was detected using our techniques. Neither did we detect a decrease in PR immunoreactivity in response to stimulation, contrary to previous studies (Hadi et al., 1994) . Nevertheless, our results are consistent
